Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
This study has been completed.
Study NCT00699764.   Last updated on June 18, 2008.
Information provided by GlaxoSmithKline
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prophylaxis Herpes Simplex
Additional conditions recognized in this trial
Herpes Genitalis
Herpes Simplex
More general conditions related to this trial
DNA Virus Infections
Genital Diseases, Female
Genital Diseases, Male
Herpesviridae Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Viral
Virus Diseases
Interventions listed in this trial
Placebo injection
Sponsors listed in this trial
GlaxoSmithKline


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services